However, the degree to which biosimilars will drive down the cost of biologic therapy remains to be seen.
Rheumatology Network Staff
What does compensation for rheumatologists look like these days? Would you choose rheumatology all over again? Here: key highlights from the Medscape Rheumatologist Compensation Report.
Post-treatment Lyme disease syndrome is a real disorder with real symptoms, say researchers.
Abnormalities in the proportion of anti-inflammatory strains may represent a potential target for therapy.
Product may be contaminated with Salmonella.
How best to protect your patients at risk for fracture? Test your knowledge with this 10-question quiz.
Moderate to high disease activity may persist.
While vitamin D may help ward off the onset of RA, it is less effective once the disease is established.
The first oral JAK inhibitor approved for both moderate to severe RA and active PsA.
Changes in circulating monocytes may contribute to pain and disease progression.